ONCOLOGY Q3区

期刊简介

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

虽然实验室和临床癌症研究需要密切联系，但基础水平的观察往往仍然远离医学应用。该杂志致力于加速将实验结果转化为临床，并再次转化为实验室进行进一步研究。这项工作的基本目的是提高癌症的临床相关知识，并改善恶性疾病的预防、诊断和治疗结果。该杂志发表来自世界各地癌症项目的重要临床研究，沿着重要的转化实验室发现、小型综述（邀请和提交）和肿瘤竞技场不断发展和有争议的主题的深入讨论。该杂志的一个独特之处是一个新的部分，重点是快速同行评审和随后发表的短期报告的第一和第二阶段的临床癌症试验，以确保高质量的临床癌症研究迅速进入公共领域的目标，无论试验的最终结论是关于疗效或毒性。

《ONCOLOGY》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： POSTHARVEST BIOLOGY AND TECHNOLOGY
• 下一篇：PARKINSONISM & RELATED DISORDERS